Travere Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results

Rhea-AI Summary

Travere Therapeutics, Inc. (NASDAQ: TVTX) announced it will disclose its fourth quarter and full year 2021 financial results on February 24, 2022, after U.S. markets close. A conference call to discuss these results and provide a business update will take place at 4:30 p.m. ET the same day. Interested parties can access a live webcast through Travere’s website. A replay of the call will be available from 7:30 p.m. ET on February 24 until March 3, 2022. For more information, visit Travere.com.

SAN DIEGO, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter and full year 2021 financial results on Thursday, February 24, 2022 after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.

Conference Call Information

Date:		Thursday, February 24, 2022
Time:		4:30 p.m. ET
Dial-in numbers:		+1 (855) 219-9219 (U.S.) or +1 (315) 625-6891 (International)
Confirmation code:		6217409
Live webcast:		Travere.com in the “Events & Presentations” section of the “Investors” page

A replay of the call will be available from 7:30 p.m. ET, February 24, 2022 to 7:30 p.m. ET, March 3, 2022. The replay number is +1 (855) 859-2056 (U.S.) or +1 (404) 537-3406 (International), confirmation code 6217409.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com

Contact:
Chris Cline, CFA
Senior Vice President, Investor Relations & Corporate Communications
888-969-7879
IR@travere.com

FAQ

When will Travere Therapeutics report its financial results for Q4 2021?

Travere Therapeutics will report its fourth quarter and full year 2021 financial results on February 24, 2022.

What time is the conference call for Travere Therapeutics' financial results?

The conference call is scheduled for 4:30 p.m. ET on February 24, 2022.

How can I access the live webcast of Travere Therapeutics' conference call?

You can access the live webcast through the 'Events & Presentations' section on Travere's website.

When will the replay of the conference call be available?

The replay will be available from 7:30 p.m. ET on February 24, 2022, to 7:30 p.m. ET on March 3, 2022.

What is the confirmation code for Travere Therapeutics' conference call?

The confirmation code for the conference call is 6217409.